...
首页> 外文期刊>Pharmacoepidemiology and drug safety >Hospitalization costs associated with warfarin-related bleeding events among older community-dwelling adults.
【24h】

Hospitalization costs associated with warfarin-related bleeding events among older community-dwelling adults.

机译:住院治疗与较旧的社区住宅成年人中的华法林相关的出血相关。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

PURPOSE: A prior paper from this study demonstrated that patient report of receiving medication instructions from health care professionals is associated with reduced risk of warfarin-related bleeding hospitalizations. The objective of this analysis was to describe the hospitalization costs due to warfarin-related bleeding events in older community-dwelling adults and to estimate the hospitalization costs avoided due to the receipt of medication instruction from different sources. METHODS: We estimated the expected hospitalization costs associated with four instruction sources based on the respective incidence rate of observed hospitalizations and mean hospitalization cost for warfarin-related bleeding episodes from a prospective cohort study of beneficiaries of the Pennsylvania Pharmaceutical Assistance Contract for the Elderly (PACE). We estimated hospitalization costs avoided due to each instruction source compared to no instructions using the payer's perspective. We conducted probabilistic sensitivity analysis to account for uncertainty in our parameters. RESULTS: One hundred twenty-six warfarin-related bleeding hospitalizations occurred during the observation period with a mean cost of Dollars 10,819 (SD: Dollars 11,536). The mean expected hospitalization cost from a warfarin-related bleeding hospitalization without instruction was Dollars 835 per year per person. Hospitalization costs avoided with instruction from a health care professional ranged from Dollars 443 to Dollars 481 per year per person. CONCLUSIONS: The costs per hospitalization associated with warfarin-related bleeding events are substantial. Instructions for warfarin management from a health care professional may reduce the number of warfarin-related bleeding hospitalizations and associated costs. Investments in interventions to improve communication regarding warfarin management may be justified economically based on the potential cost savings estimated in this study.
机译:目的:本研究的先前论文证明,患有医疗保健专业人员的药物指示的患者报告与旱法相关的出血住院风险降低有关。该分析的目的是描述由于旧的社区住宅中的华法林相关的出血事件,并且估计由于从不同来源的药物指导收到药物指导而估计住院费用。方法:我们估计,根据观察到的住院治疗的各自发病率以及来自宾夕法尼亚州的老年人受益者的受益者的预期队列研究的宾夕法尼亚州医学援助的预期队列与林法队相关出血发作的平均住院费用相关的预期住院费用。 )。由于每个指令来源与使用付款人的角度没有说明,我们估计住院费用避免。我们进行了概率敏感性分析,以解释我们参数中的不确定性。结果:在观察期内发生一百二十六华法林相关的出血住院,其平均费用10,819(SD:美元11,536)。 Warfarin相关的出血住院的平均预期住院费用无需指导是每年每年835美元。住院费用避免了从医疗保健专业人员的指示范围从美元443美元到每年481美元。结论:与华法林相关的出血事件相关的每住院费用很大。来自医疗保健专业人士的华法林管理说明可能会减少与华法林相关的出血住院和相关成本的数量。对改善华法林管理的沟通的干预措施的投资可能会根据本研究估计的潜在成本节约,以经济上的经济学证明。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号